A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia-Reference-Cited by-同舟云学术

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia

Published:2019-08-15 Issue:23 Volume:125 Page:4294-4302
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hamauchi Satoshi¹^ORCID,Furuse Junji²,Takano Toshimi³,Munemoto Yoshinori⁴,Furuya Ken⁵,Baba Hideo⁶,Takeuchi Manabu⁷,Choda Yasuhiro⁸,Higashiguchi Takashi⁹,Naito Tateaki¹⁰^ORCID,Muro Kei¹¹,Takayama Koichi¹²,Oyama Shusuke¹³,Takiguchi Toru¹⁴^ORCID,Komura Naoyuki¹⁴,Tamura Kazuo¹⁵

Affiliation:

1. Department of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan

2. Department of Medical Oncology, Faculty of Medicine Kyorin University Tokyo Japan

3. Department of Medical Oncology Toranomon Hospital Tokyo Japan

4. Department of Surgery Fukui‐ken Saiseikai Hospital Fukui Japan

5. Department of Gastroenterology and Hepatology Japan Community Health Care Organization, Hokkaido Hospital Hokkaido Japan

6. Department of Gastroenterological Surgery, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan

7. Department of Gastroenterology Nagaoka Red Cross Hospital Niigata Japan

8. Department of Surgery Hiroshima Citizens Hospital Hiroshima Japan

9. Department of Surgery and Palliative Medicine Fujita Health University School of Medicine Aichi Japan

10. Division of Thoracic Oncology Shizuoka Cancer Center Shizuoka Japan

11. Department of Clinical Oncology Aichi Cancer Center Hospital Nagoya Japan

12. Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto Japan

13. Data Science Ono Pharmaceutical Company Ltd Osaka Japan

14. Clinical Development Planning Ono Pharmaceutical Company Ltd Osaka Japan

15. General Medical Research Center Fukuoka University Fukuoka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32406

Reference43 articles.

1. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014

2. The cancer anorexia-cachexia syndrome: myth or reality?

3. Treatment of Cachexia: An Overview of Recent Developments

4. Prognostic effect of weight loss prior tochemotherapy in cancer patients

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays;European Journal of Pharmacology;2024-10

2. Use of anamorelin hydrochloride in a patient with lung cancer-related cachexia undergoing chemoradiotherapy: A case report;Current Problems in Cancer: Case Reports;2024-09

3. Impact of the Combination of Anamorelin and Rehabilitation on Functional and Nutritional Outcomes in Patients with Cancer Cachexia;Nutrition and Cancer;2024-08-29

4. Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia;BMC Palliative Care;2024-08-24

5. Long-Term Effects of Oral Nutritional Supplements After Gastrectomy for Gastric Cancer: A Survival Analysis from a Multicenter, Open-Label, Randomized Controlled Trial;Annals of Surgical Oncology;2024-07-10